Associate editor Sarah Faulkner (left) of Drug Deliver Business News interviews Bigfoot Biomedical CEO Jeffrey Brewer (right) at DeviceTalks West, December 2017 in Orange County, Calif.
Jeffrey Brewer faced the biggest challenge of his life when his 7-year-old son Sean received a diabetes diagnosis in 2002: Diabetes became the new focus for Brewer’s energy.
In his role as CEO at JDRF (formerly the Juvenile Diabetes Research Foundation) between 2011 and 2014, Brewer forged financial partnerships with industry to drive the development of insulin delivery and glucose monitoring technologies. He joined the founding of Bigfoot Biomedical in 2014 because he felt that industry could and should do more to marry the best of our technologies to automate diabetes management and make them available to the greatest number of people in need.
“This is a disease that exacts an enormous toll on the people who have it and the families around the people who have it. They’re willing to go to extraordinary lengths to live better, to be safer,” Brewer said during DeviceTalks West, held in Orange County, Calif. in December 2017.
Brewer returns for a keynote appearance at DeviceTalks Minnesota, June 4–5 in St. Paul, Minn.
Managing editor Chris Newmarker contributed to this report.
